Regenxbio (RGNX) FCF Margin Growth (5y) (2019 - 2025)
Regenxbio (RGNX) FCF Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25,312.00 |
| Sep 30, 2025 | -16,871.00 |
| Jun 30, 2025 | -6,674.00 |
| Mar 31, 2025 | 26,531.00 |
| Dec 31, 2024 | 7,386.00 |
| Sep 30, 2024 | -1,485.00 |
| Jun 30, 2024 | 17,464.00 |
| Mar 31, 2024 | 322,681.00 |
| Dec 31, 2023 | -12,479.00 |
| Sep 30, 2023 | 7,858.00 |
| Jun 30, 2023 | -36,864.00 |
| Mar 31, 2023 | -49,013.00 |
| Dec 31, 2022 | 66,136.00 |
| Sep 30, 2022 | 111,678.00 |
| Jun 30, 2022 | 1,718.00 |
| Mar 31, 2022 | 418,471.00 |
| Dec 31, 2021 | 156,823.00 |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 21,926.00 |
| Mar 31, 2021 | 186,093.00 |